Sökning: "treatment effect heterogeneity"
Visar resultat 11 - 15 av 103 avhandlingar innehållade orden treatment effect heterogeneity.
11. Mismatch repair deficiency in colorectal cancer : prognosis and prediction for basic treatment strategies
Sammanfattning : Colorectal cancer (CRC) remains a significant healthcare problem worldwide, being the third most common cancer and the fourth most frequent cause of cancer death. Environmental and dietary factors such as alcohol abuse, cigarette smoking, and genetic predisposition seem to constitute the main aetiologies. LÄS MER
12. Essays on Panel Data with Multidimensional Unobserved Heterogeneity
Sammanfattning : This thesis contributes to econometric methodology in terms of estimation and inference in static panel data models with unobserved multidimensional heterogeneity. When not properly accounted for, unobserved heterogeneity may introduce bias into the parameter estimates associated with covariates of interest, such as treatment indicators or determinants of macroeconomic indicators. LÄS MER
13. Understanding the heterogeneity of the hematopoietic stem cells
Sammanfattning : The hematopoietic system is replenished and maintained throughout life by rare hematopoietic stem cells (HSCs) that reside in the bone marrow (BM) of adult mammals. Over the last 20 years, the advancement in the field lead to the acknowledgement of the heterogeneity within the HSC compartment unraveling the presence of HSC subsets with certain mature blood lineage preferences so called lineage-biased (Li-bi) HSCs. LÄS MER
14. Human gonadotrophins for ovarian stimulation in infertility treatment
Sammanfattning : Infertility problems are present in 10 to 15 % of couples of fertile age. Ovulatory dysfunction, as a single cause, can be successfully treated and in-vitro fertilisation (IVF) can help a considerable number of couples, also when male problems are present. LÄS MER
15. Pharmacometric Evaluation of Biomarkers to Improve Treatment in Oncology
Sammanfattning : Cancer is a family of many different diseases with substantial heterogeneity also within the same cancer type. In the era of personalized medicine, it is desirable to identify an early response to treatment (i.e., a biomarker) that can predict the long-term outcome with respect to both safety and efficacy. LÄS MER